nodes	percent_of_prediction	percent_of_DWPC	metapath
Meloxicam—PTGS1—esophageal cancer	0.293	0.636	CbGaD
Meloxicam—PGD—Methotrexate—esophageal cancer	0.211	0.562	CbGbCtD
Meloxicam—PTGS2—esophageal cancer	0.168	0.364	CbGaD
Meloxicam—ABCC4—Methotrexate—esophageal cancer	0.0581	0.155	CbGbCtD
Meloxicam—PTGS2—Cisplatin—esophageal cancer	0.0526	0.14	CbGbCtD
Meloxicam—CYP2C9—Capecitabine—esophageal cancer	0.0355	0.0948	CbGbCtD
Meloxicam—CYP2C9—Cisplatin—esophageal cancer	0.0179	0.0477	CbGbCtD
Meloxicam—Lornoxicam—PTGS1—esophageal cancer	0.00119	0.261	CrCbGaD
Meloxicam—Tenoxicam—PTGS1—esophageal cancer	0.00106	0.232	CrCbGaD
Meloxicam—PGD—neck—esophageal cancer	0.000931	0.113	CbGeAlD
Meloxicam—Lornoxicam—PTGS2—esophageal cancer	0.000681	0.149	CrCbGaD
Meloxicam—Piroxicam—PTGS1—esophageal cancer	0.000656	0.143	CrCbGaD
Meloxicam—PGD—bronchus—esophageal cancer	0.000624	0.0759	CbGeAlD
Meloxicam—PGD—smooth muscle tissue—esophageal cancer	0.00061	0.0742	CbGeAlD
Meloxicam—Tenoxicam—PTGS2—esophageal cancer	0.000607	0.133	CrCbGaD
Meloxicam—PGD—trachea—esophageal cancer	0.00056	0.0681	CbGeAlD
Meloxicam—PGD—digestive system—esophageal cancer	0.000482	0.0586	CbGeAlD
Meloxicam—ABCC4—bronchus—esophageal cancer	0.000444	0.054	CbGeAlD
Meloxicam—PGD—lung—esophageal cancer	0.000402	0.049	CbGeAlD
Meloxicam—Piroxicam—PTGS2—esophageal cancer	0.000375	0.082	CrCbGaD
Meloxicam—ABCC4—digestive system—esophageal cancer	0.000343	0.0417	CbGeAlD
Meloxicam—ABCC4—lung—esophageal cancer	0.000286	0.0348	CbGeAlD
Meloxicam—PGD—lymph node—esophageal cancer	0.000275	0.0335	CbGeAlD
Meloxicam—PTGS1—epithelium—esophageal cancer	0.000265	0.0323	CbGeAlD
Meloxicam—Abdominal pain upper—Capecitabine—esophageal cancer	0.000257	0.00339	CcSEcCtD
Meloxicam—PTGS1—smooth muscle tissue—esophageal cancer	0.000255	0.0311	CbGeAlD
Meloxicam—Visual impairment—Cisplatin—esophageal cancer	0.000254	0.00336	CcSEcCtD
Meloxicam—PTGS2—epithelium—esophageal cancer	0.000253	0.0308	CbGeAlD
Meloxicam—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000253	0.00334	CcSEcCtD
Meloxicam—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000253	0.00334	CcSEcCtD
Meloxicam—Nasopharyngitis—Capecitabine—esophageal cancer	0.000251	0.00332	CcSEcCtD
Meloxicam—PTGS2—bronchus—esophageal cancer	0.00025	0.0304	CbGeAlD
Meloxicam—Gastritis—Capecitabine—esophageal cancer	0.000249	0.00328	CcSEcCtD
Meloxicam—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000248	0.00327	CcSEcCtD
Meloxicam—Eye disorder—Cisplatin—esophageal cancer	0.000247	0.00325	CcSEcCtD
Meloxicam—Tinnitus—Cisplatin—esophageal cancer	0.000246	0.00325	CcSEcCtD
Meloxicam—Cardiac disorder—Cisplatin—esophageal cancer	0.000245	0.00323	CcSEcCtD
Meloxicam—Flushing—Cisplatin—esophageal cancer	0.000245	0.00323	CcSEcCtD
Meloxicam—PTGS2—smooth muscle tissue—esophageal cancer	0.000244	0.0297	CbGeAlD
Meloxicam—Asthma—Capecitabine—esophageal cancer	0.000243	0.00321	CcSEcCtD
Meloxicam—Influenza—Capecitabine—esophageal cancer	0.000243	0.00321	CcSEcCtD
Meloxicam—Bronchospasm—Capecitabine—esophageal cancer	0.000239	0.00315	CcSEcCtD
Meloxicam—Photosensitivity—Methotrexate—esophageal cancer	0.000238	0.00315	CcSEcCtD
Meloxicam—Immune system disorder—Cisplatin—esophageal cancer	0.000238	0.00315	CcSEcCtD
Meloxicam—Mediastinal disorder—Cisplatin—esophageal cancer	0.000238	0.00314	CcSEcCtD
Meloxicam—Angina pectoris—Capecitabine—esophageal cancer	0.000237	0.00312	CcSEcCtD
Meloxicam—Sweating increased—Capecitabine—esophageal cancer	0.000237	0.00312	CcSEcCtD
Meloxicam—Arrhythmia—Cisplatin—esophageal cancer	0.000236	0.00311	CcSEcCtD
Meloxicam—PTGS1—trachea—esophageal cancer	0.000234	0.0285	CbGeAlD
Meloxicam—Bronchitis—Capecitabine—esophageal cancer	0.000234	0.00308	CcSEcCtD
Meloxicam—Alopecia—Cisplatin—esophageal cancer	0.000233	0.00308	CcSEcCtD
Meloxicam—Abdominal discomfort—Capecitabine—esophageal cancer	0.000233	0.00307	CcSEcCtD
Meloxicam—Hepatic failure—Methotrexate—esophageal cancer	0.000233	0.00307	CcSEcCtD
Meloxicam—Pancytopenia—Capecitabine—esophageal cancer	0.000231	0.00305	CcSEcCtD
Meloxicam—Erythema—Cisplatin—esophageal cancer	0.00023	0.00303	CcSEcCtD
Meloxicam—Malnutrition—Cisplatin—esophageal cancer	0.00023	0.00303	CcSEcCtD
Meloxicam—Renal failure acute—Methotrexate—esophageal cancer	0.000227	0.00299	CcSEcCtD
Meloxicam—Flatulence—Cisplatin—esophageal cancer	0.000226	0.00299	CcSEcCtD
Meloxicam—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000226	0.00298	CcSEcCtD
Meloxicam—PTGS2—trachea—esophageal cancer	0.000224	0.0273	CbGeAlD
Meloxicam—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000222	0.00293	CcSEcCtD
Meloxicam—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000222	0.00293	CcSEcCtD
Meloxicam—Weight increased—Capecitabine—esophageal cancer	0.000221	0.00292	CcSEcCtD
Meloxicam—CYP2C9—digestive system—esophageal cancer	0.000221	0.0269	CbGeAlD
Meloxicam—Visual disturbance—Methotrexate—esophageal cancer	0.000221	0.00291	CcSEcCtD
Meloxicam—Muscle spasms—Cisplatin—esophageal cancer	0.000221	0.00291	CcSEcCtD
Meloxicam—Weight decreased—Capecitabine—esophageal cancer	0.00022	0.0029	CcSEcCtD
Meloxicam—Infestation NOS—Capecitabine—esophageal cancer	0.000217	0.00286	CcSEcCtD
Meloxicam—Infestation—Capecitabine—esophageal cancer	0.000217	0.00286	CcSEcCtD
Meloxicam—Vision blurred—Cisplatin—esophageal cancer	0.000216	0.00286	CcSEcCtD
Meloxicam—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000216	0.00285	CcSEcCtD
Meloxicam—Tremor—Cisplatin—esophageal cancer	0.000215	0.00284	CcSEcCtD
Meloxicam—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000215	0.00283	CcSEcCtD
Meloxicam—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000214	0.00282	CcSEcCtD
Meloxicam—Ill-defined disorder—Cisplatin—esophageal cancer	0.000213	0.00281	CcSEcCtD
Meloxicam—Renal failure—Capecitabine—esophageal cancer	0.000213	0.00281	CcSEcCtD
Meloxicam—Myocardial infarction—Capecitabine—esophageal cancer	0.000212	0.0028	CcSEcCtD
Meloxicam—Anaemia—Cisplatin—esophageal cancer	0.000212	0.0028	CcSEcCtD
Meloxicam—Jaundice—Capecitabine—esophageal cancer	0.000211	0.00279	CcSEcCtD
Meloxicam—Stomatitis—Capecitabine—esophageal cancer	0.000211	0.00279	CcSEcCtD
Meloxicam—Conjunctivitis—Capecitabine—esophageal cancer	0.000211	0.00278	CcSEcCtD
Meloxicam—Urinary tract infection—Capecitabine—esophageal cancer	0.000211	0.00278	CcSEcCtD
Meloxicam—Malaise—Cisplatin—esophageal cancer	0.000207	0.00273	CcSEcCtD
Meloxicam—Haematuria—Capecitabine—esophageal cancer	0.000207	0.00273	CcSEcCtD
Meloxicam—Leukopenia—Cisplatin—esophageal cancer	0.000206	0.00271	CcSEcCtD
Meloxicam—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000205	0.0027	CcSEcCtD
Meloxicam—Agranulocytosis—Capecitabine—esophageal cancer	0.000202	0.00267	CcSEcCtD
Meloxicam—PTGS1—digestive system—esophageal cancer	0.000202	0.0245	CbGeAlD
Meloxicam—Convulsion—Cisplatin—esophageal cancer	0.000199	0.00263	CcSEcCtD
Meloxicam—Mood swings—Methotrexate—esophageal cancer	0.000198	0.00262	CcSEcCtD
Meloxicam—ABCC4—lymph node—esophageal cancer	0.000196	0.0238	CbGeAlD
Meloxicam—Myalgia—Cisplatin—esophageal cancer	0.000196	0.00258	CcSEcCtD
Meloxicam—Haemoglobin—Capecitabine—esophageal cancer	0.000195	0.00258	CcSEcCtD
Meloxicam—Rhinitis—Capecitabine—esophageal cancer	0.000195	0.00257	CcSEcCtD
Meloxicam—Anxiety—Cisplatin—esophageal cancer	0.000195	0.00257	CcSEcCtD
Meloxicam—Hepatitis—Capecitabine—esophageal cancer	0.000194	0.00257	CcSEcCtD
Meloxicam—Haemorrhage—Capecitabine—esophageal cancer	0.000194	0.00257	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000194	0.00256	CcSEcCtD
Meloxicam—Liver function test abnormal—Methotrexate—esophageal cancer	0.000193	0.00255	CcSEcCtD
Meloxicam—Discomfort—Cisplatin—esophageal cancer	0.000193	0.00255	CcSEcCtD
Meloxicam—Pharyngitis—Capecitabine—esophageal cancer	0.000193	0.00255	CcSEcCtD
Meloxicam—PTGS2—digestive system—esophageal cancer	0.000193	0.0235	CbGeAlD
Meloxicam—Urinary tract disorder—Capecitabine—esophageal cancer	0.000192	0.00254	CcSEcCtD
Meloxicam—Oedema peripheral—Capecitabine—esophageal cancer	0.000192	0.00253	CcSEcCtD
Meloxicam—Connective tissue disorder—Capecitabine—esophageal cancer	0.000191	0.00252	CcSEcCtD
Meloxicam—Urethral disorder—Capecitabine—esophageal cancer	0.000191	0.00252	CcSEcCtD
Meloxicam—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000188	0.00249	CcSEcCtD
Meloxicam—Oedema—Cisplatin—esophageal cancer	0.000187	0.00247	CcSEcCtD
Meloxicam—Anaphylactic shock—Cisplatin—esophageal cancer	0.000187	0.00247	CcSEcCtD
Meloxicam—Visual impairment—Capecitabine—esophageal cancer	0.000187	0.00247	CcSEcCtD
Meloxicam—Infection—Cisplatin—esophageal cancer	0.000186	0.00246	CcSEcCtD
Meloxicam—Erythema multiforme—Capecitabine—esophageal cancer	0.000184	0.00243	CcSEcCtD
Meloxicam—Nervous system disorder—Cisplatin—esophageal cancer	0.000184	0.00243	CcSEcCtD
Meloxicam—Thrombocytopenia—Cisplatin—esophageal cancer	0.000184	0.00242	CcSEcCtD
Meloxicam—Tachycardia—Cisplatin—esophageal cancer	0.000183	0.00241	CcSEcCtD
Meloxicam—Skin disorder—Cisplatin—esophageal cancer	0.000182	0.0024	CcSEcCtD
Meloxicam—Eye disorder—Capecitabine—esophageal cancer	0.000182	0.0024	CcSEcCtD
Meloxicam—Tinnitus—Capecitabine—esophageal cancer	0.000181	0.00239	CcSEcCtD
Meloxicam—Hyperhidrosis—Cisplatin—esophageal cancer	0.000181	0.00239	CcSEcCtD
Meloxicam—Asthma—Methotrexate—esophageal cancer	0.000181	0.00239	CcSEcCtD
Meloxicam—Cardiac disorder—Capecitabine—esophageal cancer	0.00018	0.00238	CcSEcCtD
Meloxicam—Flushing—Capecitabine—esophageal cancer	0.00018	0.00238	CcSEcCtD
Meloxicam—Pancreatitis—Methotrexate—esophageal cancer	0.000177	0.00234	CcSEcCtD
Meloxicam—Angiopathy—Capecitabine—esophageal cancer	0.000176	0.00233	CcSEcCtD
Meloxicam—Immune system disorder—Capecitabine—esophageal cancer	0.000176	0.00232	CcSEcCtD
Meloxicam—Mediastinal disorder—Capecitabine—esophageal cancer	0.000175	0.00231	CcSEcCtD
Meloxicam—Hypotension—Cisplatin—esophageal cancer	0.000175	0.00231	CcSEcCtD
Meloxicam—Arrhythmia—Capecitabine—esophageal cancer	0.000174	0.00229	CcSEcCtD
Meloxicam—Abdominal discomfort—Methotrexate—esophageal cancer	0.000173	0.00229	CcSEcCtD
Meloxicam—Alopecia—Capecitabine—esophageal cancer	0.000172	0.00227	CcSEcCtD
Meloxicam—Pancytopenia—Methotrexate—esophageal cancer	0.000172	0.00227	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000171	0.00225	CcSEcCtD
Meloxicam—Mental disorder—Capecitabine—esophageal cancer	0.00017	0.00225	CcSEcCtD
Meloxicam—Erythema—Capecitabine—esophageal cancer	0.000169	0.00223	CcSEcCtD
Meloxicam—Malnutrition—Capecitabine—esophageal cancer	0.000169	0.00223	CcSEcCtD
Meloxicam—CYP3A4—digestive system—esophageal cancer	0.000168	0.0205	CbGeAlD
Meloxicam—PTGS1—lung—esophageal cancer	0.000168	0.0205	CbGeAlD
Meloxicam—Paraesthesia—Cisplatin—esophageal cancer	0.000168	0.00222	CcSEcCtD
Meloxicam—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000168	0.00222	CcSEcCtD
Meloxicam—Dyspnoea—Cisplatin—esophageal cancer	0.000167	0.00221	CcSEcCtD
Meloxicam—Flatulence—Capecitabine—esophageal cancer	0.000167	0.0022	CcSEcCtD
Meloxicam—Dysgeusia—Capecitabine—esophageal cancer	0.000166	0.00219	CcSEcCtD
Meloxicam—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000165	0.00218	CcSEcCtD
Meloxicam—Back pain—Capecitabine—esophageal cancer	0.000164	0.00216	CcSEcCtD
Meloxicam—Decreased appetite—Cisplatin—esophageal cancer	0.000163	0.00215	CcSEcCtD
Meloxicam—Muscle spasms—Capecitabine—esophageal cancer	0.000163	0.00215	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000162	0.00214	CcSEcCtD
Meloxicam—Drowsiness—Methotrexate—esophageal cancer	0.000161	0.00213	CcSEcCtD
Meloxicam—Infestation NOS—Methotrexate—esophageal cancer	0.000161	0.00213	CcSEcCtD
Meloxicam—Infestation—Methotrexate—esophageal cancer	0.000161	0.00213	CcSEcCtD
Meloxicam—PTGS2—lung—esophageal cancer	0.000161	0.0196	CbGeAlD
Meloxicam—Pain—Cisplatin—esophageal cancer	0.00016	0.00212	CcSEcCtD
Meloxicam—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00016	0.00211	CcSEcCtD
Meloxicam—Vision blurred—Capecitabine—esophageal cancer	0.00016	0.00211	CcSEcCtD
Meloxicam—Tremor—Capecitabine—esophageal cancer	0.000159	0.00209	CcSEcCtD
Meloxicam—Renal failure—Methotrexate—esophageal cancer	0.000159	0.00209	CcSEcCtD
Meloxicam—Stomatitis—Methotrexate—esophageal cancer	0.000157	0.00207	CcSEcCtD
Meloxicam—Ill-defined disorder—Capecitabine—esophageal cancer	0.000157	0.00207	CcSEcCtD
Meloxicam—Conjunctivitis—Methotrexate—esophageal cancer	0.000157	0.00207	CcSEcCtD
Meloxicam—Anaemia—Capecitabine—esophageal cancer	0.000156	0.00207	CcSEcCtD
Meloxicam—Sweating—Methotrexate—esophageal cancer	0.000155	0.00204	CcSEcCtD
Meloxicam—Feeling abnormal—Cisplatin—esophageal cancer	0.000154	0.00204	CcSEcCtD
Meloxicam—Haematuria—Methotrexate—esophageal cancer	0.000154	0.00203	CcSEcCtD
Meloxicam—Malaise—Capecitabine—esophageal cancer	0.000153	0.00202	CcSEcCtD
Meloxicam—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000153	0.00201	CcSEcCtD
Meloxicam—Vertigo—Capecitabine—esophageal cancer	0.000152	0.00201	CcSEcCtD
Meloxicam—Syncope—Capecitabine—esophageal cancer	0.000152	0.002	CcSEcCtD
Meloxicam—Leukopenia—Capecitabine—esophageal cancer	0.000152	0.002	CcSEcCtD
Meloxicam—Agranulocytosis—Methotrexate—esophageal cancer	0.00015	0.00199	CcSEcCtD
Meloxicam—Palpitations—Capecitabine—esophageal cancer	0.00015	0.00197	CcSEcCtD
Meloxicam—Loss of consciousness—Capecitabine—esophageal cancer	0.000149	0.00196	CcSEcCtD
Meloxicam—Body temperature increased—Cisplatin—esophageal cancer	0.000148	0.00196	CcSEcCtD
Meloxicam—Cough—Capecitabine—esophageal cancer	0.000148	0.00195	CcSEcCtD
Meloxicam—Hypertension—Capecitabine—esophageal cancer	0.000146	0.00193	CcSEcCtD
Meloxicam—Haemoglobin—Methotrexate—esophageal cancer	0.000145	0.00192	CcSEcCtD
Meloxicam—Haemorrhage—Methotrexate—esophageal cancer	0.000145	0.00191	CcSEcCtD
Meloxicam—Hepatitis—Methotrexate—esophageal cancer	0.000145	0.00191	CcSEcCtD
Meloxicam—Myalgia—Capecitabine—esophageal cancer	0.000144	0.0019	CcSEcCtD
Meloxicam—Arthralgia—Capecitabine—esophageal cancer	0.000144	0.0019	CcSEcCtD
Meloxicam—Pharyngitis—Methotrexate—esophageal cancer	0.000144	0.0019	CcSEcCtD
Meloxicam—Anxiety—Capecitabine—esophageal cancer	0.000144	0.0019	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000143	0.00189	CcSEcCtD
Meloxicam—Urinary tract disorder—Methotrexate—esophageal cancer	0.000143	0.00189	CcSEcCtD
Meloxicam—Discomfort—Capecitabine—esophageal cancer	0.000142	0.00188	CcSEcCtD
Meloxicam—Urethral disorder—Methotrexate—esophageal cancer	0.000142	0.00187	CcSEcCtD
Meloxicam—Dry mouth—Capecitabine—esophageal cancer	0.000141	0.00186	CcSEcCtD
Meloxicam—Visual impairment—Methotrexate—esophageal cancer	0.00014	0.00184	CcSEcCtD
Meloxicam—Confusional state—Capecitabine—esophageal cancer	0.000139	0.00184	CcSEcCtD
Meloxicam—Oedema—Capecitabine—esophageal cancer	0.000138	0.00182	CcSEcCtD
Meloxicam—Hypersensitivity—Cisplatin—esophageal cancer	0.000138	0.00182	CcSEcCtD
Meloxicam—Infection—Capecitabine—esophageal cancer	0.000137	0.00181	CcSEcCtD
Meloxicam—Erythema multiforme—Methotrexate—esophageal cancer	0.000137	0.00181	CcSEcCtD
Meloxicam—Shock—Capecitabine—esophageal cancer	0.000136	0.00179	CcSEcCtD
Meloxicam—Nervous system disorder—Capecitabine—esophageal cancer	0.000135	0.00179	CcSEcCtD
Meloxicam—Eye disorder—Methotrexate—esophageal cancer	0.000135	0.00179	CcSEcCtD
Meloxicam—Thrombocytopenia—Capecitabine—esophageal cancer	0.000135	0.00179	CcSEcCtD
Meloxicam—Tinnitus—Methotrexate—esophageal cancer	0.000135	0.00178	CcSEcCtD
Meloxicam—Tachycardia—Capecitabine—esophageal cancer	0.000135	0.00178	CcSEcCtD
Meloxicam—Asthenia—Cisplatin—esophageal cancer	0.000134	0.00178	CcSEcCtD
Meloxicam—Cardiac disorder—Methotrexate—esophageal cancer	0.000134	0.00177	CcSEcCtD
Meloxicam—Skin disorder—Capecitabine—esophageal cancer	0.000134	0.00177	CcSEcCtD
Meloxicam—Hyperhidrosis—Capecitabine—esophageal cancer	0.000134	0.00176	CcSEcCtD
Meloxicam—Angiopathy—Methotrexate—esophageal cancer	0.000131	0.00173	CcSEcCtD
Meloxicam—Immune system disorder—Methotrexate—esophageal cancer	0.000131	0.00173	CcSEcCtD
Meloxicam—Mediastinal disorder—Methotrexate—esophageal cancer	0.00013	0.00172	CcSEcCtD
Meloxicam—Hypotension—Capecitabine—esophageal cancer	0.000129	0.0017	CcSEcCtD
Meloxicam—Diarrhoea—Cisplatin—esophageal cancer	0.000128	0.00169	CcSEcCtD
Meloxicam—Alopecia—Methotrexate—esophageal cancer	0.000128	0.00169	CcSEcCtD
Meloxicam—Mental disorder—Methotrexate—esophageal cancer	0.000127	0.00167	CcSEcCtD
Meloxicam—Erythema—Methotrexate—esophageal cancer	0.000126	0.00166	CcSEcCtD
Meloxicam—Malnutrition—Methotrexate—esophageal cancer	0.000126	0.00166	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000126	0.00166	CcSEcCtD
Meloxicam—Insomnia—Capecitabine—esophageal cancer	0.000125	0.00165	CcSEcCtD
Meloxicam—Paraesthesia—Capecitabine—esophageal cancer	0.000124	0.00164	CcSEcCtD
Meloxicam—Dysgeusia—Methotrexate—esophageal cancer	0.000123	0.00163	CcSEcCtD
Meloxicam—Dyspnoea—Capecitabine—esophageal cancer	0.000123	0.00163	CcSEcCtD
Meloxicam—Back pain—Methotrexate—esophageal cancer	0.000122	0.00161	CcSEcCtD
Meloxicam—Dyspepsia—Capecitabine—esophageal cancer	0.000122	0.00161	CcSEcCtD
Meloxicam—Decreased appetite—Capecitabine—esophageal cancer	0.00012	0.00159	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000119	0.00157	CcSEcCtD
Meloxicam—Vomiting—Cisplatin—esophageal cancer	0.000119	0.00157	CcSEcCtD
Meloxicam—Fatigue—Capecitabine—esophageal cancer	0.000119	0.00157	CcSEcCtD
Meloxicam—Vision blurred—Methotrexate—esophageal cancer	0.000119	0.00157	CcSEcCtD
Meloxicam—Rash—Cisplatin—esophageal cancer	0.000118	0.00156	CcSEcCtD
Meloxicam—Pain—Capecitabine—esophageal cancer	0.000118	0.00156	CcSEcCtD
Meloxicam—Constipation—Capecitabine—esophageal cancer	0.000118	0.00156	CcSEcCtD
Meloxicam—Dermatitis—Cisplatin—esophageal cancer	0.000118	0.00156	CcSEcCtD
Meloxicam—Ill-defined disorder—Methotrexate—esophageal cancer	0.000117	0.00154	CcSEcCtD
Meloxicam—Anaemia—Methotrexate—esophageal cancer	0.000116	0.00154	CcSEcCtD
Meloxicam—PTGS1—lymph node—esophageal cancer	0.000115	0.014	CbGeAlD
Meloxicam—Feeling abnormal—Capecitabine—esophageal cancer	0.000114	0.0015	CcSEcCtD
Meloxicam—Malaise—Methotrexate—esophageal cancer	0.000114	0.0015	CcSEcCtD
Meloxicam—Vertigo—Methotrexate—esophageal cancer	0.000113	0.00149	CcSEcCtD
Meloxicam—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000113	0.00149	CcSEcCtD
Meloxicam—Leukopenia—Methotrexate—esophageal cancer	0.000113	0.00149	CcSEcCtD
Meloxicam—Nausea—Cisplatin—esophageal cancer	0.000111	0.00147	CcSEcCtD
Meloxicam—PTGS2—lymph node—esophageal cancer	0.00011	0.0134	CbGeAlD
Meloxicam—Cough—Methotrexate—esophageal cancer	0.00011	0.00145	CcSEcCtD
Meloxicam—Urticaria—Capecitabine—esophageal cancer	0.00011	0.00145	CcSEcCtD
Meloxicam—Abdominal pain—Capecitabine—esophageal cancer	0.000109	0.00144	CcSEcCtD
Meloxicam—Body temperature increased—Capecitabine—esophageal cancer	0.000109	0.00144	CcSEcCtD
Meloxicam—Convulsion—Methotrexate—esophageal cancer	0.000109	0.00144	CcSEcCtD
Meloxicam—Myalgia—Methotrexate—esophageal cancer	0.000107	0.00142	CcSEcCtD
Meloxicam—Arthralgia—Methotrexate—esophageal cancer	0.000107	0.00142	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000107	0.00141	CcSEcCtD
Meloxicam—Discomfort—Methotrexate—esophageal cancer	0.000106	0.0014	CcSEcCtD
Meloxicam—Confusional state—Methotrexate—esophageal cancer	0.000104	0.00137	CcSEcCtD
Meloxicam—Anaphylactic shock—Methotrexate—esophageal cancer	0.000103	0.00136	CcSEcCtD
Meloxicam—Infection—Methotrexate—esophageal cancer	0.000102	0.00135	CcSEcCtD
Meloxicam—Hypersensitivity—Capecitabine—esophageal cancer	0.000102	0.00134	CcSEcCtD
Meloxicam—Nervous system disorder—Methotrexate—esophageal cancer	0.000101	0.00133	CcSEcCtD
Meloxicam—Thrombocytopenia—Methotrexate—esophageal cancer	0.000101	0.00133	CcSEcCtD
Meloxicam—Skin disorder—Methotrexate—esophageal cancer	9.99e-05	0.00132	CcSEcCtD
Meloxicam—Hyperhidrosis—Methotrexate—esophageal cancer	9.94e-05	0.00131	CcSEcCtD
Meloxicam—Asthenia—Capecitabine—esophageal cancer	9.91e-05	0.00131	CcSEcCtD
Meloxicam—Pruritus—Capecitabine—esophageal cancer	9.77e-05	0.00129	CcSEcCtD
Meloxicam—Hypotension—Methotrexate—esophageal cancer	9.61e-05	0.00127	CcSEcCtD
Meloxicam—Diarrhoea—Capecitabine—esophageal cancer	9.45e-05	0.00125	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Methotrexate—esophageal cancer	9.37e-05	0.00124	CcSEcCtD
Meloxicam—Insomnia—Methotrexate—esophageal cancer	9.3e-05	0.00123	CcSEcCtD
Meloxicam—Paraesthesia—Methotrexate—esophageal cancer	9.23e-05	0.00122	CcSEcCtD
Meloxicam—Dyspnoea—Methotrexate—esophageal cancer	9.17e-05	0.00121	CcSEcCtD
Meloxicam—Somnolence—Methotrexate—esophageal cancer	9.14e-05	0.00121	CcSEcCtD
Meloxicam—Dizziness—Capecitabine—esophageal cancer	9.14e-05	0.00121	CcSEcCtD
Meloxicam—Dyspepsia—Methotrexate—esophageal cancer	9.05e-05	0.0012	CcSEcCtD
Meloxicam—Decreased appetite—Methotrexate—esophageal cancer	8.94e-05	0.00118	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Methotrexate—esophageal cancer	8.88e-05	0.00117	CcSEcCtD
Meloxicam—Fatigue—Methotrexate—esophageal cancer	8.87e-05	0.00117	CcSEcCtD
Meloxicam—Pain—Methotrexate—esophageal cancer	8.79e-05	0.00116	CcSEcCtD
Meloxicam—Vomiting—Capecitabine—esophageal cancer	8.78e-05	0.00116	CcSEcCtD
Meloxicam—Rash—Capecitabine—esophageal cancer	8.71e-05	0.00115	CcSEcCtD
Meloxicam—Dermatitis—Capecitabine—esophageal cancer	8.7e-05	0.00115	CcSEcCtD
Meloxicam—Headache—Capecitabine—esophageal cancer	8.65e-05	0.00114	CcSEcCtD
Meloxicam—Feeling abnormal—Methotrexate—esophageal cancer	8.48e-05	0.00112	CcSEcCtD
Meloxicam—Gastrointestinal pain—Methotrexate—esophageal cancer	8.41e-05	0.00111	CcSEcCtD
Meloxicam—Nausea—Capecitabine—esophageal cancer	8.21e-05	0.00108	CcSEcCtD
Meloxicam—Urticaria—Methotrexate—esophageal cancer	8.17e-05	0.00108	CcSEcCtD
Meloxicam—Abdominal pain—Methotrexate—esophageal cancer	8.13e-05	0.00107	CcSEcCtD
Meloxicam—Body temperature increased—Methotrexate—esophageal cancer	8.13e-05	0.00107	CcSEcCtD
Meloxicam—Hypersensitivity—Methotrexate—esophageal cancer	7.58e-05	0.001	CcSEcCtD
Meloxicam—Asthenia—Methotrexate—esophageal cancer	7.38e-05	0.000974	CcSEcCtD
Meloxicam—Pruritus—Methotrexate—esophageal cancer	7.28e-05	0.000961	CcSEcCtD
Meloxicam—Diarrhoea—Methotrexate—esophageal cancer	7.04e-05	0.000929	CcSEcCtD
Meloxicam—Dizziness—Methotrexate—esophageal cancer	6.8e-05	0.000898	CcSEcCtD
Meloxicam—Vomiting—Methotrexate—esophageal cancer	6.54e-05	0.000863	CcSEcCtD
Meloxicam—Rash—Methotrexate—esophageal cancer	6.48e-05	0.000856	CcSEcCtD
Meloxicam—Dermatitis—Methotrexate—esophageal cancer	6.48e-05	0.000855	CcSEcCtD
Meloxicam—Headache—Methotrexate—esophageal cancer	6.44e-05	0.00085	CcSEcCtD
Meloxicam—Nausea—Methotrexate—esophageal cancer	6.11e-05	0.000806	CcSEcCtD
Meloxicam—ABCC4—Hemostasis—NOS2—esophageal cancer	3.2e-05	0.000422	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ADH7—esophageal cancer	3.18e-05	0.00042	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PLCE1—esophageal cancer	3.18e-05	0.00042	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.14e-05	0.000415	CbGpPWpGaD
Meloxicam—PGD—Disease—NOS3—esophageal cancer	3.12e-05	0.000413	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	3.12e-05	0.000412	CbGpPWpGaD
Meloxicam—PTGS2—Disease—FKBP1A—esophageal cancer	3.08e-05	0.000407	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—MYC—esophageal cancer	3.05e-05	0.000403	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	3.02e-05	0.000399	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	3.02e-05	0.000398	CbGpPWpGaD
Meloxicam—PTGS2—Disease—DOCK2—esophageal cancer	3.01e-05	0.000398	CbGpPWpGaD
Meloxicam—PTGS2—Disease—WIF1—esophageal cancer	3.01e-05	0.000398	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—EGFR—esophageal cancer	2.99e-05	0.000394	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	2.98e-05	0.000394	CbGpPWpGaD
Meloxicam—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	2.98e-05	0.000393	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CA1—esophageal cancer	2.97e-05	0.000392	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—SLC10A2—esophageal cancer	2.97e-05	0.000392	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	2.93e-05	0.000387	CbGpPWpGaD
Meloxicam—PGD—Metabolism—CREBBP—esophageal cancer	2.92e-05	0.000386	CbGpPWpGaD
Meloxicam—PGD—Disease—ERBB2—esophageal cancer	2.92e-05	0.000386	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—CREBBP—esophageal cancer	2.87e-05	0.000379	CbGpPWpGaD
Meloxicam—PGD—Disease—PTGS2—esophageal cancer	2.86e-05	0.000377	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—SLC52A3—esophageal cancer	2.84e-05	0.000375	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—BLVRB—esophageal cancer	2.84e-05	0.000375	CbGpPWpGaD
Meloxicam—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	2.84e-05	0.000375	CbGpPWpGaD
Meloxicam—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	2.8e-05	0.00037	CbGpPWpGaD
Meloxicam—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	2.8e-05	0.00037	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ADH1B—esophageal cancer	2.79e-05	0.000368	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CSNK1A1—esophageal cancer	2.78e-05	0.000367	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CA2—esophageal cancer	2.72e-05	0.000359	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—TYMP—esophageal cancer	2.67e-05	0.000352	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.65e-05	0.000351	CbGpPWpGaD
Meloxicam—PGD—Metabolism—NOS3—esophageal cancer	2.62e-05	0.000346	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	2.6e-05	0.000344	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CYP26A1—esophageal cancer	2.59e-05	0.000342	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	2.59e-05	0.000342	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—NOS3—esophageal cancer	2.57e-05	0.000339	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	2.54e-05	0.000335	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ALOX15—esophageal cancer	2.53e-05	0.000334	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PLCE1—esophageal cancer	2.52e-05	0.000333	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ADH7—esophageal cancer	2.52e-05	0.000333	CbGpPWpGaD
Meloxicam—PTGS2—Spinal Cord Injury—TP53—esophageal cancer	2.51e-05	0.000331	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	2.5e-05	0.000331	CbGpPWpGaD
Meloxicam—PGD—Disease—CDKN1A—esophageal cancer	2.5e-05	0.00033	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.5e-05	0.00033	CbGpPWpGaD
Meloxicam—ABCC4—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.48e-05	0.000328	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—SLC10A2—esophageal cancer	2.42e-05	0.000319	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CA1—esophageal cancer	2.42e-05	0.000319	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—TPI1—esophageal cancer	2.41e-05	0.000318	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GSTO1—esophageal cancer	2.41e-05	0.000318	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PTGS2—esophageal cancer	2.39e-05	0.000316	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	2.38e-05	0.000315	CbGpPWpGaD
Meloxicam—PGD—Disease—EP300—esophageal cancer	2.38e-05	0.000314	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ELMO1—esophageal cancer	2.34e-05	0.000309	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—BLVRB—esophageal cancer	2.31e-05	0.000305	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—SLC52A3—esophageal cancer	2.31e-05	0.000305	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ALDOB—esophageal cancer	2.31e-05	0.000305	CbGpPWpGaD
Meloxicam—PTGS2—Disease—GSTO1—esophageal cancer	2.28e-05	0.000302	CbGpPWpGaD
Meloxicam—PTGS2—Disease—TPI1—esophageal cancer	2.28e-05	0.000302	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GAPDH—esophageal cancer	2.22e-05	0.000294	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ADH1B—esophageal cancer	2.21e-05	0.000292	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CA2—esophageal cancer	2.21e-05	0.000292	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CRABP1—esophageal cancer	2.2e-05	0.000291	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ALDOB—esophageal cancer	2.19e-05	0.000289	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.16e-05	0.000285	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—TYMP—esophageal cancer	2.12e-05	0.000279	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HIST1H2BM—esophageal cancer	2.11e-05	0.000278	CbGpPWpGaD
Meloxicam—PTGS2—Disease—GAPDH—esophageal cancer	2.11e-05	0.000278	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GNG7—esophageal cancer	2.1e-05	0.000277	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	2.08e-05	0.000274	CbGpPWpGaD
Meloxicam—PGD—Disease—MYC—esophageal cancer	2.07e-05	0.000273	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	2.07e-05	0.000273	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYP26A1—esophageal cancer	2.06e-05	0.000272	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PLCE1—esophageal cancer	2.05e-05	0.000271	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ADH7—esophageal cancer	2.05e-05	0.000271	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	2.03e-05	0.000268	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.03e-05	0.000268	CbGpPWpGaD
Meloxicam—PGD—Disease—EGFR—esophageal cancer	2.03e-05	0.000267	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ALOX15—esophageal cancer	2.01e-05	0.000265	CbGpPWpGaD
Meloxicam—PGD—Metabolism—EP300—esophageal cancer	1.99e-05	0.000263	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CA1—esophageal cancer	1.97e-05	0.00026	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—SLC10A2—esophageal cancer	1.97e-05	0.00026	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ALDH2—esophageal cancer	1.96e-05	0.00026	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—EP300—esophageal cancer	1.95e-05	0.000258	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—TPI1—esophageal cancer	1.91e-05	0.000253	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GSTO1—esophageal cancer	1.91e-05	0.000253	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GSTT1—esophageal cancer	1.87e-05	0.000247	CbGpPWpGaD
Meloxicam—PTGS2—Disease—XIAP—esophageal cancer	1.86e-05	0.000246	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CYP2A6—esophageal cancer	1.85e-05	0.000244	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.84e-05	0.000243	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ALDOB—esophageal cancer	1.83e-05	0.000242	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ADH1B—esophageal cancer	1.8e-05	0.000238	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CA2—esophageal cancer	1.8e-05	0.000238	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GAPDH—esophageal cancer	1.77e-05	0.000233	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	1.76e-05	0.000233	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.76e-05	0.000232	CbGpPWpGaD
Meloxicam—PGD—Disease—PIK3CA—esophageal cancer	1.76e-05	0.000232	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ENO1—esophageal cancer	1.75e-05	0.000231	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CRABP1—esophageal cancer	1.75e-05	0.000231	CbGpPWpGaD
Meloxicam—PTGS2—Disease—B2M—esophageal cancer	1.73e-05	0.000229	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PSME2—esophageal cancer	1.73e-05	0.000228	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PSME1—esophageal cancer	1.73e-05	0.000228	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—TYMP—esophageal cancer	1.72e-05	0.000227	CbGpPWpGaD
Meloxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	1.71e-05	0.000225	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP26A1—esophageal cancer	1.67e-05	0.000221	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PLCE1—esophageal cancer	1.67e-05	0.000221	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ADH7—esophageal cancer	1.67e-05	0.000221	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GNG7—esophageal cancer	1.66e-05	0.00022	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ENO1—esophageal cancer	1.66e-05	0.000219	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.65e-05	0.000218	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PSME1—esophageal cancer	1.64e-05	0.000216	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PSME2—esophageal cancer	1.64e-05	0.000216	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ALOX15—esophageal cancer	1.63e-05	0.000216	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CALR—esophageal cancer	1.57e-05	0.000207	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ALDH2—esophageal cancer	1.56e-05	0.000206	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GSTO1—esophageal cancer	1.56e-05	0.000206	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—TPI1—esophageal cancer	1.56e-05	0.000206	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—BLVRB—esophageal cancer	1.53e-05	0.000201	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SLC52A3—esophageal cancer	1.53e-05	0.000201	CbGpPWpGaD
Meloxicam—PTGS2—Disease—FBXW7—esophageal cancer	1.52e-05	0.000201	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.51e-05	0.000199	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ALDOB—esophageal cancer	1.49e-05	0.000197	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CYP1B1—esophageal cancer	1.49e-05	0.000197	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GSTT1—esophageal cancer	1.48e-05	0.000196	CbGpPWpGaD
Meloxicam—PGD—Metabolism—PIK3CA—esophageal cancer	1.47e-05	0.000194	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYP2A6—esophageal cancer	1.47e-05	0.000194	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ADH1B—esophageal cancer	1.47e-05	0.000194	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.46e-05	0.000193	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—PIK3CA—esophageal cancer	1.45e-05	0.000191	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GAPDH—esophageal cancer	1.44e-05	0.00019	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CRABP1—esophageal cancer	1.42e-05	0.000188	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—TYMP—esophageal cancer	1.4e-05	0.000185	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CYP19A1—esophageal cancer	1.4e-05	0.000185	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—TP53—esophageal cancer	1.4e-05	0.000185	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PTGS1—esophageal cancer	1.39e-05	0.000184	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ENO1—esophageal cancer	1.39e-05	0.000184	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PSME1—esophageal cancer	1.37e-05	0.000181	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PSME2—esophageal cancer	1.37e-05	0.000181	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP26A1—esophageal cancer	1.36e-05	0.00018	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GNG7—esophageal cancer	1.35e-05	0.000179	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ALOX15—esophageal cancer	1.33e-05	0.000175	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CA1—esophageal cancer	1.3e-05	0.000171	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SLC10A2—esophageal cancer	1.3e-05	0.000171	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—HMOX1—esophageal cancer	1.28e-05	0.000169	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ALDH2—esophageal cancer	1.27e-05	0.000168	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—TPI1—esophageal cancer	1.27e-05	0.000167	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GSTO1—esophageal cancer	1.27e-05	0.000167	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.25e-05	0.000166	CbGpPWpGaD
Meloxicam—PTGS2—Disease—TGFBR2—esophageal cancer	1.23e-05	0.000162	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ABCB1—esophageal cancer	1.23e-05	0.000162	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ALDOB—esophageal cancer	1.21e-05	0.00016	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GSTT1—esophageal cancer	1.21e-05	0.000159	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP2A6—esophageal cancer	1.19e-05	0.000158	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.19e-05	0.000157	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CA2—esophageal cancer	1.19e-05	0.000157	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYP1B1—esophageal cancer	1.18e-05	0.000156	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GAPDH—esophageal cancer	1.17e-05	0.000154	CbGpPWpGaD
Meloxicam—PTGS2—Disease—SMAD4—esophageal cancer	1.16e-05	0.000154	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CRABP1—esophageal cancer	1.16e-05	0.000153	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ENO1—esophageal cancer	1.13e-05	0.000149	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PTGS1—esophageal cancer	1.13e-05	0.000149	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PSME2—esophageal cancer	1.11e-05	0.000147	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PSME1—esophageal cancer	1.11e-05	0.000147	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYP19A1—esophageal cancer	1.11e-05	0.000147	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ADH7—esophageal cancer	1.1e-05	0.000146	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.1e-05	0.000146	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GNG7—esophageal cancer	1.1e-05	0.000146	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ALDH2—esophageal cancer	1.03e-05	0.000136	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—HMOX1—esophageal cancer	1.01e-05	0.000134	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.95e-06	0.000131	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GSTT1—esophageal cancer	9.83e-06	0.00013	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ABCB1—esophageal cancer	9.73e-06	0.000129	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	9.73e-06	0.000129	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP2A6—esophageal cancer	9.71e-06	0.000128	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	9.67e-06	0.000128	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ADH1B—esophageal cancer	9.67e-06	0.000128	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP1B1—esophageal cancer	9.62e-06	0.000127	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HIF1A—esophageal cancer	9.51e-06	0.000126	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.27e-06	0.000122	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—TYMP—esophageal cancer	9.24e-06	0.000122	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ENO1—esophageal cancer	9.21e-06	0.000122	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PTGS1—esophageal cancer	9.21e-06	0.000122	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PSME1—esophageal cancer	9.07e-06	0.00012	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PSME2—esophageal cancer	9.07e-06	0.00012	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP19A1—esophageal cancer	9.04e-06	0.000119	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP26A1—esophageal cancer	8.99e-06	0.000119	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ALOX15—esophageal cancer	8.76e-06	0.000116	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NOS2—esophageal cancer	8.65e-06	0.000114	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NOTCH1—esophageal cancer	8.57e-06	0.000113	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTO1—esophageal cancer	8.36e-06	0.00011	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—TPI1—esophageal cancer	8.36e-06	0.00011	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—HMOX1—esophageal cancer	8.25e-06	0.000109	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CREBBP—esophageal cancer	8.2e-06	0.000108	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	8.1e-06	0.000107	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ALDOB—esophageal cancer	8.01e-06	0.000106	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.92e-06	0.000105	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ABCB1—esophageal cancer	7.92e-06	0.000105	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP1B1—esophageal cancer	7.83e-06	0.000103	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CREBBP—esophageal cancer	7.77e-06	0.000103	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GAPDH—esophageal cancer	7.71e-06	0.000102	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CRABP1—esophageal cancer	7.64e-06	0.000101	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP19A1—esophageal cancer	7.36e-06	9.72e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.36e-06	9.72e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—NOS3—esophageal cancer	7.34e-06	9.69e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GNG7—esophageal cancer	7.27e-06	9.6e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NOS3—esophageal cancer	6.96e-06	9.19e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ALDH2—esophageal cancer	6.81e-06	9e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—HMOX1—esophageal cancer	6.72e-06	8.87e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PTGS2—esophageal cancer	6.71e-06	8.86e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.59e-06	8.7e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CREBBP—esophageal cancer	6.51e-06	8.59e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ERBB2—esophageal cancer	6.51e-06	8.59e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTT1—esophageal cancer	6.48e-06	8.56e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ABCB1—esophageal cancer	6.45e-06	8.51e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP2A6—esophageal cancer	6.41e-06	8.46e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ENO1—esophageal cancer	6.07e-06	8.02e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PTGS1—esophageal cancer	6.07e-06	8.02e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.99e-06	7.91e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PSME2—esophageal cancer	5.98e-06	7.9e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PSME1—esophageal cancer	5.98e-06	7.9e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—NOS3—esophageal cancer	5.83e-06	7.69e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—EP300—esophageal cancer	5.58e-06	7.37e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CDKN1A—esophageal cancer	5.56e-06	7.34e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CREBBP—esophageal cancer	5.29e-06	6.99e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—EP300—esophageal cancer	5.29e-06	6.99e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP1B1—esophageal cancer	5.16e-06	6.82e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.87e-06	6.44e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP19A1—esophageal cancer	4.85e-06	6.41e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—NOS3—esophageal cancer	4.74e-06	6.26e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MYC—esophageal cancer	4.61e-06	6.09e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—EGFR—esophageal cancer	4.51e-06	5.96e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—EP300—esophageal cancer	4.43e-06	5.85e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—HMOX1—esophageal cancer	4.43e-06	5.85e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PTGS2—esophageal cancer	4.34e-06	5.73e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CREBBP—esophageal cancer	4.31e-06	5.69e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ABCB1—esophageal cancer	4.25e-06	5.62e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PIK3CA—esophageal cancer	4.13e-06	5.45e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PIK3CA—esophageal cancer	3.91e-06	5.17e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—NOS3—esophageal cancer	3.86e-06	5.09e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—EP300—esophageal cancer	3.61e-06	4.76e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PTGS2—esophageal cancer	3.53e-06	4.66e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PIK3CA—esophageal cancer	3.28e-06	4.33e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—EP300—esophageal cancer	2.93e-06	3.88e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.84e-06	3.75e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PIK3CA—esophageal cancer	2.67e-06	3.52e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—NOS3—esophageal cancer	2.54e-06	3.36e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PTGS2—esophageal cancer	2.33e-06	3.07e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PIK3CA—esophageal cancer	2.17e-06	2.87e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—EP300—esophageal cancer	1.94e-06	2.56e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.43e-06	1.89e-05	CbGpPWpGaD
